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Abstract
In the brain, extracellular adenosine increases as a result of neuronal activity. The mechanisms by which this occurs are only
incompletely understood. Here we investigate the hypothesis that the Na+ influxes associated with neuronal signalling
activate the Na+-K+ ATPase which, by consuming ATP, generates intracellular adenosine that is then released via
transporters. By measuring adenosine release directly with microelectrode biosensors, we have demonstrated that AMPA-
receptor evoked adenosine release in basal forebrain and cortex depends on extracellular Na+. We have simultaneously
imaged intracellular Na+ and measured adenosine release. The accumulation of intracellular Na+ during AMPA receptor
activation preceded adenosine release by some 90 s. By removing extracellular Ca2+, and thus preventing indiscriminate
neuronal activation, we used ouabain to test the role of the Na+-K+ ATPase in the release of adenosine. Under conditions
which caused a Na+ influx, brief applications of ouabain increased the accumulation of intracellular Na+ but conversely
rapidly reduced extracellular adenosine levels. In addition, ouabain greatly reduced the amount of adenosine released
during application of AMPA. Our data therefore suggest that activity of the Na+-K+ ATPase is directly linked to the efflux of
adenosine and could provide a universal mechanism that couples adenosine release to neuronal activity. The Na+-K+
ATPase-dependent adenosine efflux is likely to provide adenosine-mediated activity-dependent negative feedback that will
be important in many diverse functional contexts including the regulation of sleep.
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Introduction
Adenosine is perhaps the most pervasive modulator in the brain,
where it can act at a number of G-protein coupled receptors [1] to
modulate neuronal and network activity [2–5]. For example
adenosine is an endogenous somnogen and is very important for
the homeostatic control of sleep [6]. Acting via A1 receptors
adenosine universally mediates presynaptic inhibition of glutama-
tergic synapses [3]. It is increasingly apparent that the extracellular
concentration of adenosine can be increased as a result of neural
activity, allowing adenosine to mediate state-dependent actions
that depend on prior activity in the nervous system [7–13]. Some
of this adenosine arises from prior release of ATP from astrocytes.
However there is evidence for direct adenosine release from
neurons. In the cerebellum this arises from exocytosis, but in other
brain regions, such as hippocampus and cortex, direct activity-
dependent release of adenosine appears to be mediated via
facilitative transporters [12].
The link between neural activity and the production of
intracellular adenosine which can be transported into the
extracellular space remains unclear. There has been a general
idea that the metabolic load of neuronal signalling causes
consumption of ATP with consequent production of intracellular
adenosine; this would then be extruded from the cell by adenosine
clearance mechanisms such as facilitative transporters. Together,
these two systems would represent activity-dependent release of
adenosine into the extracellular environment. Most of the resting
metabolic load of the brain is consumed by the pumps that restore
the differential concentration of Na+ across membranes [14]. An
attractive hypothesis is therefore that activation of the Na+-K+
ATPase can cause rapid transporter-mediated release of adeno-
sine. As this hypothesis has not been directly tested, we have used a
combination of adenosine biosensing and Na+ imaging to directly
evaluate the role of the Na+-K+ ATPase in activity dependent
adenosine release. We have examined adenosine release mecha-
nisms in primary motor cortex and the basal forebrain (BFB), a
region connected to the control of slow wave sleep. In both areas
we find that activation of the Na+-K+ ATPase is linked to the
accumulation of extracellular adenosine.
Methods
Slice Preparation
300 mm-thick (400 mm-thick for imaging) coronal slices includ-
ing the basal forebrain were obtained from 18–30-day-old, male,
Sprague-Dawley rats. All animal handling was carried out in strict
accordance with the UK Animals (Scientific Procedures) Act 1986
(licence PPL 80/2493) with all efforts made to minimise suffering.
Animals were sacrificed by cervical dislocation and the brain was
rapidly extracted and placed in a sub 24uC artificial cerebrospinal
fluid (aCSF; see below for composition) containing an additional
10 mM MgCl2. Slices were cut on a Microm HM 650 V
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microslicer (Carl Zeiss, Welwyn Garden City, UK) and then
transferred to a holding chamber at room temperature in standard
aCSF composed of (in mM): NaCl, 124; KCl, 3; CaCl2, 2;
NaHCO3, 26, NaH2PO4, 1.2; MgSO4, 1; glucose, 10; equilibrated
with 95%:5% O2:CO2 to pH 7.4. Slices were incubated for at
least one hour prior to initial experiments.
Biosensor recording and analysis
Individual slices were placed on a nylon net, submerged in a
recording chamber perfused with 32–33uC aCSF at a flow rate of
5–6 ml/min which was recycled, allowing sufficient run-out to
waste during solution changes for different drug applications to
avoid contamination of solutions. Microelectrode biosensors
(Sarissa Biomedical, Coventry, UK) were carefully placed in the
slice in pairs, one adenosine (ADO) sensitive and the other Null
(lacking any enzymes), in BFB and cortex so that the active region
was fully in the slice. We have previously published detailed
accounts of the biosensor characteristics and use [15–19]. The
Null sensors act as a control for any non-specific signals; the traces
illustrated are the difference between the ADO and Null sensors.
The ADO sensors will respond to adenosine, inosine and
hypoxanthine and thus give a total purine signal, although most
of this signal arises from adenosine in this application [19]. The
biosensor signals were normalized to the sensitivity of the
biosensor to 10 mM adenosine.
The areas of the BFB used were the horizontal arm of the
diagonal band of Broca or substantia innominata. In the coronal
slices at the same antero-posterior level as the BFB the cortex is
primary motor cortex. The biosensors were placed into the middle
of the cortical layer giving an approximate localization in layer 5
(Fig 1A). Initial insertion of biosensors resulted in a transient
purinergic response (20–40 minutes), which was allowed to decay
before experiments commenced. After the experiments were
completed, the biosensors were withdrawn from the slice and
calibrated with aCSF containing 10 mM adenosine, followed by
aCSF with 10 mM serotonin to check that the sensor was
adequately shielded and thus insensitive to other electro-active
biological substrates. All drugs were bath applied by addition to
the aCSF, and were tested to ensure they did not directly interfere
with biosensor sensitivity.
Biosensor signals were measured on a Duo-Stat ME200+
potentiostat (Sarissa Biomedical, Coventry, UK) and acquired on a
DT3010 data acquisition board (Data Translation, Bietigheim-
Bissingen, Germany). Offline data analysis was done with
customised software. Adenosine concentrations were measured
at peak, and data are presented as mean 6 standard error of the
mean. We used a time of 10% peak to represent the start of
concentration rises in order to discriminate from potential noise in
the baseline. All statistics were carried out using unpaired students
T-test.
Measurement of intracellular Na+
The ratiometric dye, SBFI (sodium-binding benzofuran iso-
phthalate; Invitrogen), was used to measure Na+. SBFI-AM was
loaded into neurons and astrocytes via injection from a pipette of
the AM dye into the centre of the slice (Fig 1B). After some 20
minutes neurons and astrocytes had taken up sufficient dye to
allow measurements to commence. The slices were mounted in a
flow chamber and visualized with an Olympus BX51 microscope
through a 606 water immersion objective. An Andor Ixon EM-
CCD was used to collect the images. Illumination at 340 and
380 nm was provided by a mercury arc lamp (Cairn Research)
and a monochromator (Optoscan, Cairn Research). Metafluor
software (Cairn Research) was used to control the experiments and
store and analyze the data. Biosensors were placed into the slice,
and the imaging regions arranged such that Na+ was measured
close to the location of the biosensors.
Zero Ca2+ aCSF
To remove Ca2+ signalling we modified standard aCSF by
including 1 mM EGTA (ethylene glycol-bis(2-aminoethylether)-
N,N,N9,N9-tetraacetic acid) and substituting Ca2+ with additional
Mg2+. In the initial experiments with ouabain we also included
cyclopiazonic acid at 20 mM, to block the Ca2+-ATPase in the
endoplasmic reticulum and hence deplete intracellular stores.
However we found that zero extracellular Ca2+ alone was
sufficient to block the indirect actions of ouabain and did not
include cyclopiazonic acid in later experiments.
Results
We have previously shown that certain depolarizing stimuli,
most notably activation of AMPA (2-amino-3-(3-hydroxy-5-
methyl-isoxazol-4-yl)propanoic acid) receptors, reliably evoke
adenosine release in the basal forebrain (BFB) and cortex [19].
As this release of adenosine is independent of both intracellular
and extracellular Ca2+ [19], we tested whether an influx of Na+
might trigger adenosine release. Substitution of 80% of extracel-
Figure 1. Biosensor placement and example of SBFI loading. A) Photograph of the slice in the holding chamber demonstrating biosensor
placement in basal forebrain (BFB) and cortex. B) Representative example of SBFI loading at 340 nm excitation, showing loaded neurons (red arrows)
and astrocytes (green arrows).
doi:10.1371/journal.pone.0087481.g001
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lular Na+ with NMDG, completely and reversibly blocked AMPA-
evoked adenosine release in both the BFB and cortex (Fig 2A,B).
The substitution of Na+ also blocked the ability of high K+ to
evoke adenosine release in BFB but not in cortex (Fig 2C). The
difference in Na+-dependence of high K+-evoked AMPA release
between BFB and cortex is curious, and may be related to the
different types of cells and relative proportions of astrocytes and
neurons in the two areas.
The AMPA-evoked adenosine release was also sensitive to
TTX, which substantially, but not completely (.60% block),
inhibited adenosine release in both BFB and cortex evoked by
AMPA and high K+ (Fig 2D–F). The Na+-dependent adenosine
efflux could occur via the Na+ linked concentrative nucleoside
transporters (CNTs). Although the CNTs normally take up
adenosine from the extracellular space (because of the Na+
gradient from outside to inside the cell), the accumulation of
intracellular Na+ and depolarization from AMPA receptor
activation could transiently reverse the driving force on the CNTs
in dendritic spines and cause an efflux of adenosine as can happen
for glutamate under some circumstances [21] However neither
preincubation with 100 mM uridine for 1 hour (a competitive
substrate for the CNTs [20]; Fig 3A) nor 200 mM phloridzin (an
inhibitor of many Na+-dependent transport processes [22]; Fig 3B)
affected the AMPA-evoked adenosine efflux, leading us to discount
this possibility.
An alternative pathway for release of adenosine could be via the
equilibrative nucleoside transporters (ENTs). We therefore applied
20 mM dipyridamole (DIPY; Fig 3C) alone or 20 mM DIPY plus
10 mM NBTI (nitrobenzylthioinosine; blockers of the ENTs;
Fig 3D). DIPY alone reduced adenosine release in response to
AMPA application from 2.460.5 and 7.261.0 mM (n= 13, BFB
and cortex respectively) in the control to 1.560.4 mM and
4.360.8 mM (n= 13, BFB and cortex respectively). In the BFB,
but not the cortex, this reduction was statistically significant:
p = 0.031, DIPY vs control for BFB; and p=0.104, DIPY vs
control for cortex (Student’s t-test). However the combination of
NBTI and DIPY was without any significant effect in either BFB
or cortex: control, 2.360.5 and 13.562.1 mM (n= 9, BFB and
cortex respectively); NBTI/DIPY, 2.260.5 (n = 16) and
11.561.72 mM (n= 17), BFB and cortex respectively. We think
that the statistical significance of the effect of DIPY on its own in
BFB is most probably a type 1 statistical error (false rejection of the
null hypothesis) as we could not repeat this result with the
combination of transport blockers that should have been more
effective at reducing adenosine efflux (e.g. [13,17]). It therefore
seems safest to conclude that the adenosine efflux evoked by
AMPA application in BFB and cortex is not mediated via
transporters that are sensitive to NBTI/DIPY.
We next used the ratiometric dye SBFI, to measure the
accumulation of intracellular Na+ in both astrocytes and neurons,
Figure 2. AMPA receptor evoked adenosine release depends upon a Na+ influx in cortex and basal forebrain. A) Adenosine biosensor
recording, showing that when 80% of Na+ was substituted with NMDG+, AMPA (5 mM) could not evoke adenosine release in basal forebrain (BFB) or
cortex (CTX). Re-introduction of Na+ restored AMPA-evoked adenosine release. B) Summary data showing that AMPA-evoked adenosine release in
BFB and cortex is completely dependent on extracellular Na+ (n = 6). C) High K+-evoked adenosine release depends upon extracellular Na+ in BFB but
not in cortex (n = 6). D,E) AMPA-evoked adenosine release was substantially blocked by TTX. f) TTX also blocked high K+-evoked adenosine release in
cortex (control, n = 10; TTX n=12). Statistical comparisons via Student’s unpaired t-test.
doi:10.1371/journal.pone.0087481.g002
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identified on the basis of their morphology and size (Fig 1B).
AMPA application readily caused a detectable increase of
intracellular Na+ (peak change in fluorescence ratio
0.03460.008 in neurons and 0.02660.005 in astrocytes; Fig 4A).
This increase commenced after 100614 s, n= 8 (time to 10% of
peak rise) after the application of AMPA and was followed after a
delay of about 90 s by a rapid increase in extracellular adenosine
(achieved 189613 s, n= 8, time to 10% of peak rise, after the
application of AMPA). Both the adenosine biosensor recordings
and Na+ imaging can resolve events on a second to second
timescale e.g. [8,11,23]. This substantial delay between the
increase in Na+ and the release of adenosine is therefore biological
in origin and suggests that the link between these two events is
indirect. This is consistent with our conclusion that a direct Na+-
mediated transport mechanism is not involved in the Na+-
dependent adenosine release.
The Na+ influx will activate Na+-K+ ATPases and cause
additional consumption of ATP. The enzyme adenylate kinase will
utilize ADP to convert it back to ATP with the production of
AMP. This AMP can then be broken down to adenosine by the 59
nucleotidase. These coupled reactions are required to keep
intracellular ADP levels low and thus keep the ATP:ADP ratio
very high, thereby allowing ATP hydrolysis to drive coupled
reactions in the cell. ATP hydrolysis thus results in increases in the
concentration of intracellular adenosine. In neurons, which have
very little adenosine kinase [24], which converts adenosine to AMP,
this adenosine could reach sufficient concentrations to then enter
the extracellular space via an, as yet uncharacterized, transporter.
It is therefore possible to make a plausible and clear prediction that
activation of the Na+-K+ ATPases may cause an efflux of
adenosine.
The obvious tool to test involvement of the Na+-K+ ATPase is
ouabain. However, by reducing the activity of the Na+-K+
ATPases, ouabain causes general depolarization of neurons and
release of many transmitters with consequent multiple indirect
actions. As we have described in hippocampus [17], brief
application of ouabain (100 mM) under control conditions
increased intracellular Na+ and caused profound adenosine release
(4.361.0 mM, n= 3 in BFB; and 38.664.9 mM, n= 3 in cortex,
Fig 4B). However part of this adenosine release may have arisen
from the indiscriminate activation of neurons and networks caused
by the powerful depolarising actions of ouabain.
We therefore exploited the Ca2+-independence of adenosine
release [19] in our experiments as a way of preventing these
indirect actions of ouabain. When extracellular Ca2+ was removed
from the aCSF, ouabain did not cause adenosine release,
confirming that the previously observed release (in the presence
of extracellular Ca2+) was an indirect consequence of the non-
specific neuronal and network activation caused by ouabain
(Fig 4B). Indeed, ouabain application in the absence of extracel-
lular Ca2+ often caused a decrease in extracellular adenosine
(Fig 4B, see below). This observation meant that we could use
ouabain as a tool to probe the cell-specific role of the Na+-K+
ATPase under conditions of zero extracellular Ca2+.
We reasoned that following an increase in intracellular Na+ and
consequent adenosine release, application of ouabain, by reducing
ATP consumption via the Na+-K+ ATPases should inhibit the
adenosine efflux. Exposure of slices to zero Ca2+ aCSF caused a
gradual increase in intracellular Na+ in the BFB and cortex as
measured by SBFI fluorescence (Fig 4C,D). This is expected given
that hypocalcaemic conditions have long been known to increase
membrane excitability [25] and increase Na+ influx through
channels and exchangers [26,27], and removal of extracellular
Ca2+ will open pannexin and connexin hemichannels. These
hemichannels are non-selective large conductances present in a
variety of neurons [28–31] and would allow Na+-entry.
This modest increase in intracellular Na+, which we observed
on removal of extracellular Ca2+, was accompanied after a short
delay by an increase in extracellular adenosine (mean increase in
BFB and cortex respectively 1.060.4 mM, n= 12 and
7.161.6 mM, n= 12). Brief application of 100 mM ouabain
resulted in a further rapid increase in intracellular Na+ indicating
that ouabain had blocked the Na+-K+ ATPase (Fig 4C,D).
Crucially this increase in intracellular Na+ was followed by a
Figure 3. Na+-dependent concentrative nucleoside transporters (CNTs) and equilibrative nucleoside transporters (ENTs) do not
play a role in AMPA-evoked adenosine efflux. A) Preincubation of slices (for 1 h) with a competing substrate for the CNTs, 100 mM uridine, had
no effect on adenosine release in basal forebrain (BFB) or cortex (CTX). B) Application of 200 mM phloridzin, a general blocker of Na+-dependent
transporters including the CNTs had no effect on adenosine release either. C) Addition of the ENT blocker dipyramidole (DIPY; 20 mM) prior to AMPA
application caused a significant reduction in BFB adenosine release but not CTX. D) Application of both 20 mM DIPY and 10 mM NBTI (another ENT
blocker) however did not significantly reduce adenosine release in BFB or CTX.
doi:10.1371/journal.pone.0087481.g003
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rapid drop in extracellular adenosine (Fig 4C,D, arrow, mean
decrease adenosine concentration in BFB and cortex respectively
0.460.1 mM, n= 11 and 5.861.4 mM, n= 12). As the actions of
ouabain washed out, intracellular levels of Na+ started to fall
(Fig 4C,D), and the extracellular concentration of adenosine rose
as Na+-K+ ATPase activity resumed and possibly other Na+-
dependent ATP-consuming processes became activated.
We next tested whether ouabain altered the adenosine efflux
stimulated by activation of AMPA receptors. Once again, to
reduce the secondary effects of ouabain, we performed these
experiments under conditions of zero extracellular Ca2+. We used
two experimental paradigms. Firstly a 2 minute simultaneous
application of AMPA plus 100 mM ouabain was compared to 2
minute application of AMPA alone. We found that simultaneous
application of ouabain greatly reduced the amplitude of the
AMPA-evoked adenosine release, and cut short the duration of
adenosine release in both cortex and BFB compared to AMPA
alone (Fig 5A). In the BFB, the adenosine levels increased
markedly as the ouabain washed out and the Na+-K+ ATPase
became active (compare to Fig 4C). In cortex the adenosine levels
went below the preceding baseline, probably because the
conditions of zero Ca2+ cause an increase in intracellular Na+,
increased activation of the Na+-K+ ATPase and consequent
increase in the adenosine tone (compare to Fig 4D), which was
then additionally counteracted by ouabain. Secondly, we applied
100 mM ouabain prior to the application of AMPA. Although
ouabain altered the extracellular adenosine levels, once these had
stabilized, subsequent application of AMPA caused very little
further adenosine release (Fig 5B, compare inset to Fig 2). Overall
these two experimental paradigms demonstrated that the efflux of
adenosine resulting from the activation of AMPA receptors was
greatly reduced by ouabain.
Discussion
Infusion of adenosine into a single hippocampal pyramidal cell
will cause depression of the synaptic inputs to that cell via
activation of A1 receptors, suggesting that elevated levels of
intracellular adenosine will readily be transported into the
extracellular space [32,33]. On this basis, any process that
increases endogenous adenosine levels in neurons should therefore
also affect its extracellular concentration. Metabolic processes that
consume ATP will cause an increase in intracellular adenosine. As
a very large proportion of the brain’s energy budget is consumed
by neurons pumping out the Na+ that has entered during
signalling [14], the activation of the Na+-K+ ATPases is an
attractive candidate mechanism to underlie a significant degree of
activity-dependent adenosine efflux. The adenosine concentrations
observed in this study are slightly higher than the reported EC50s
of the adenosine A1 receptor of around 1 mM, measured with
respect to presynaptic inhibition of neurotransmission ([15,34,35].
These levels are also higher than the levels of adenosine release
seen in response to neuronal activation by stimulation of axon
tracts in cerebellum [9,11,13] and hippocampus [13]. Nevertheless
these are not saturating concentrations with respect to the A1
receptor, and the larger amount of release is most probably due to
the fact that AMPA application in the bathing medium will cause
a global excitation that likely exceeds what will be observed in vivo.
Figure 4. Adenosine release depends upon activation of the Na+-K+ ATPase via accumulation of intracellular Na+. A) Simultaneous
measurement of intracellular concentration of Na+ with SBFI, and adenosine release during AMPA receptor activation (5 mM AMPA) in basal forebrain.
Note the increase in intracellular Na+ precedes the adenosine release recorded by the biosensor (ADO). Black trace, neuron; green trace, astrocyte. B)
Application of 100 mM ouabain caused adenosine release in BFB and cortex in presence of normal extracellular Ca2+. In the absence of extracellular
Ca2+ ouabain caused either no change in extracellular adenosine or a reduction in adenosine. C) In BFB, application of zero Ca2+ aCSF caused an
increase in intracellular Na+ in neurons (back, blue, red) and astrocytes (green) traces as measured by SBFI. Simultaneous recording with an adenosine
biosensor showed an increase in extracellular adenosine following shortly after this increase in intracellular Na+. When ouabain was applied,
intracellular Na+ levels increased in all cells, but the extracellular adenosine levels initially fell (arrow), before increasing as ouabain washed out. D) In
cortex a similar pattern was seen: zero Ca2+ aCSF caused an increase in intracellular Na+ in neurons (back, blue, red) accompanied after a short delay
by the release of adenosine measured by the nearby biosensor. When 100 mM ouabain was applied, adenosine levels fell (arrow) despite the increase
in intracellular Na+.
doi:10.1371/journal.pone.0087481.g004
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Colocalization of AMPA receptors and the Na+-K+ ATPase
Our study suggests that activation of AMPA receptors will give a
discrete and reproducible adenosine efflux that depends on the
additional activation of the Na+-K+ ATPase resulting from the
Na+ influx through the AMPA channel. This link between
activation of AMPA receptors and adenosine release may be
explained by the subcellular localization of the Na+-K+ ATPase
and its physical proximity to AMPA receptors. These pumps are
located in dendritic spines [36] and colocalize with AMPA
receptors [37]. There are also reports that AMPA receptor
subunits coimmunoprecipitate with subunits of the Na+-K+
ATPase suggesting that they form a complex [38]. The close
proximity between these two molecules may plausibly help to
ensure that the Na+ influx resulting from AMPA receptor
activation will efficiently activate the Na+-K+ ATPase with a
resulting efflux of adenosine. We propose that adenosine efflux
linked to the activation of the Na+-K+ ATPase during neural
signalling may be important in many contexts: the setting of
general excitability levels in the brain; responses to seizure activity;
and the release of adenosine connected to the control of sleep.
Network or cellular effects?
AMPA will excite many cells which could release further
transmitters that might contribute to adenosine release. This is
unlikely to significantly affect our results as the AMPA-evoked
adenosine release persists in the absence of extracellular Ca2+
which would block transmitter release from neurons and hence
prevent these indirect effects. Similarly, whilst 20% normal
extracellular Na+ after substitution with NMDG could be expected
to reduce depolarisation of cells by AMPA and reduced network
activity, depolarisation with high K+ should be expected to cause
widespread depolarisation. Finally, the fact that ouabain, also a
potent depolarising influence, reduces adenosine release in the
absence of extracellular Ca2+ means a network effect is improb-
able. A potential confounding factor is that ouabain will cause
widespread collapse of Na+ and other ionic gradients across the
cells. However, neuronal depolarisation, swelling and alteration of
ion concentrations are likely to be modest in the short timescales
within which we observe concurrent Na+ influx and adenosine
release. For example Figures 4C and 4D show that intracellular
Na+ levels have not yet achieved a plateau at the time we observed
the fall in extracellular adenosine. After a protracted period of
exposure of around 5–10 minutes, ouabain can lead to a spreading
depression-like event, which presages irreversible cell damage
[39,40].
Other mechanisms of activity-dependent adenosine
release
Activation of the Na+-K+ ATPase may explain why spiking
activity of neurons has been linked to adenosine release [12].
Nevertheless this mechanism is unlikely to be the only mechanism
for activity dependent direct adenosine release from neurons for
three reasons. Firstly, adenosine appears to be released via
exocytosis in the cerebellum [8,9,11]. Secondly, in hippocampus,
AMPA-evoked adenosine release exhibits Ca2+ dependence [13],
unlike that seen in the BFB and cortex [19]. Thirdly, although the
adenosine efflux is discrete and reproducible, there is a significant
delay between the accumulation of intracellular Na+ (which
commences as soon as the AMPA receptor channel is opened) and
the efflux of adenosine (,90 s in our experiments). This delay
presumably reflects the dynamics of the intracellular metabolism
that produces adenosine on hydrolysis of ATP. Examples of
activity-dependent adenosine release show that it is produced with
only a very short latency following neuronal activation in
cerebellum [8,9,11] and hippocampus [41]. This disparity in
timing suggests that there must be other mechanisms that more
rapidly induce activity-dependent adenosine efflux. The Na+-
dependent mechanism that we describe in this paper may be more
suited to slower activity dependent feedback that results from
integrating all sources of excitatory activity in a cell to provide
quasi-autocrine regulation of excitability.
Our study is the first experimental test of this hypothesis and
documents that activation of AMPA receptors will give a discrete
and reproducible adenosine efflux that depends on the additional
activation of the Na+-K+ ATPase resulting from the Na+ influx
through the AMPA channel. The Na+-K+ ATPase, regarded until
now as primarily controlling the intracellular milieu, must
additionally be considered as an important regulator of extracel-
lular adenosine. As Na+-K+ ATPases are expressed in all cells of
the brain this is likely to be a very general mechanism linking
neural activation to adenosine release.
By contrast to neurons, astrocytes express high levels of
adenosine kinase [24]. This enzyme by converting adenosine to
AMP keeps the intracellular level of adenosine very low in
astrocytes [42,43] and may also help to buffer any increases in
adenosine caused by activation of ATP consuming processes. The
expression of adenosine kinase in astrocytes may limit the role of
the Na+-K+ ATPase in causing adenosine release from these cells.
Nevertheless the role of astrocytes in indirectly producing
extracellular adenosine via ATP release remains important and
we have recently shown that in hippocampus, transporter-
mediated and astrocyte-mediated adenosine release are roughly
Figure 5. Inhibition of the Na+-K+ ATPase by ouabain reduces
AMPA-evoked adenosine release. Adenosine biosensor recordings
from BFB and CTX from slices were perfused with zero Ca2+ aCSF. A)
Comparison of 5 mM AMPA application (black lines) alone with
simultaneous application of 100 mM ouabain and 5 mM AMPA (red
lines). The data are presented as averages 6SD (thin lines) of 4
experiments for each condition. When applied simultaneously with
AMPA the ouabain caused the adenosine release to be cut short and
truncated compared to the adenosine release evoked by AMPA alone.
B) Preincubation with 100 mM ouabain, once the adenosine levels had
stabilized, greatly reduced the response to AMPA (5 mM). Inset:
Summary graph showing that prior treatment with ouabain greatly
inhibits the adenosine release evoked by 5 mM AMPA (mean 6 sem).
doi:10.1371/journal.pone.0087481.g005
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equal in magnitude, but differ in their kinetics, the former being
faster and briefer than the latter [13].
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